Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27,670 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.
Yang Y, Li X, Chen G, Xian Y, Zhang H, Wu Y, Yang Y, Wu J, Wang C, He S, Wang Z, Wang Y, Wang Z, Liu H, Wang X, Zhang M, Zhang J, Li J, An T, Guan H, Li L, Shang M, Yao C, Han Y, Zhang B, Gao R, Peterson ED; CTS-AMI Investigators. Yang Y, et al. Among authors: han y. JAMA. 2023 Oct 24;330(16):1534-1545. doi: 10.1001/jama.2023.19524. JAMA. 2023. PMID: 37874574 Free PMC article. Clinical Trial.
Safety and efficacy of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: One-year results from a prospective patient-level pooled analysis of NeoVas trials.
Xu K, Fu G, Xu B, Zhou Y, Su X, Liu H, Zhang Z, Yu B, Wang X, Han Y; NeoVas OPC Investigators. Xu K, et al. Among authors: han y. Catheter Cardiovasc Interv. 2019 Feb 15;93(S1):832-838. doi: 10.1002/ccd.28067. Catheter Cardiovasc Interv. 2019. PMID: 30888736
Antiplatelet effect, safety, and pharmacokinetics of vicagrel in patients with coronary artery disease undergoing percutaneous coronary intervention.
Zhao X, Ma S, Kang Y, Tang C, Liu B, Jiang H, Zheng M, Tang Y, Sun H, Liu Y, Lai X, Gong Y, Li Y, Qi Z, Ren L, Li J, Li Y, Han Y. Zhao X, et al. Among authors: han y. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 2;8(8):806-814. doi: 10.1093/ehjcvp/pvac026. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 35438151 Clinical Trial.
In-hospital outcomes of ticagrelor versus clopidogrel in patients 75 years or older with acute coronary syndrome: findings from the Improving Care for Cardiovascular Disease in China (CCC)-Acute Coronary Syndrome Project.
Yang N, Liu J, Liu J, Hao Y, Smith JSC, Huo Y, Fonarow GC, Ge J, Morgan L, Ma C, Han Y, Zhao D; Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project investigators. Yang N, et al. Among authors: han y. Age Ageing. 2022 Nov 1;51(11):afac231. doi: 10.1093/ageing/afac231. Age Ageing. 2022. PMID: 36413586 Clinical Trial.
Three-year clinical outcomes of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: A prospective patient-level pooled analysis of NeoVas trials.
Wang X, Li Y, Fu G, Xu B, Zhou Y, Su X, Liu H, Zhang Z, Yu B, Tao L, Zheng Q, Li L, Xu K, Han Y; NeoVas OPC Investigators. Wang X, et al. Among authors: han y. Catheter Cardiovasc Interv. 2023 May;101(6):967-972. doi: 10.1002/ccd.30518. Epub 2023 Mar 7. Catheter Cardiovasc Interv. 2023. PMID: 36881746
27,670 results
You have reached the last available page of results. Please see the User Guide for more information.